Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ADCTADCT
21 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ADC THERAPEUTICS SA

CITADEL ADVISORS LLC holds 2.1M shares of ADCT (ADC THERAPEUTICS SA), worth $2.2M as of 2026-Q2. The position was increased (+413.7% shares). ADCT represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.2M

Current Shares

2.1M

Total Value Change

+$805,048

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+413.7%
$2.2M0.0%$1.07
42
2026-Q1
Increased
399,721
+34.0%
$1.5M0.0%$4.05
33
2025-Q4
Decreased
298,218
-63.7%
$1.1M0.0%$3.50
0
2025-Q3
Increased
820,715
+2729.5%
$3.3M0.0%$4.02
43
2025-Q2
New
29,006
-
$77,7360.0%$2.71
33
2024-Q3
Exited
0
-100.0%
$00.0%$3.08
0
2024-Q2
Decreased
41,433
-95.7%
$130,9280.0%$3.16
0
2024-Q1
Decreased
952,464
-48.6%
$4.3M0.0%$4.49
0
2023-Q4
Decreased
1.9M
-36.0%
$3.1M0.0%$1.66
0
2023-Q3
Decreased
2.9M
-8.6%
$2.6M0.0%$0.90
0
2023-Q2
Decreased
3.2M
-5.8%
$6.8M0.0%$2.16
0
2023-Q1
Increased
3.4M
+69.4%
$6.6M0.0%$1.97
40
2022-Q4
Increased
2M
+4895.8%
$7.6M0.0%$3.84
44
2022-Q3
New
39,791
-
$192,0000.0%$4.89
35
2021-Q4
Exited
0
-100.0%
$00.0%$20.82
0
2021-Q3
Decreased
19,346
-19.4%
$525,0000.0%$26.84
0
2021-Q2
Increased
23,999
+58.3%
$584,0000.0%$24.20
35
2021-Q1
Decreased
15,162
-82.1%
$370,0000.0%$24.25
0
2020-Q4
New
84,898
-
$2.7M0.0%$31.96
36
2020-Q3
Exited
0
-100.0%
$00.0%$32.87
0
2020-Q2
New
29,738
-
$1.4M0.0%$45.94
35

Other major holders of ADCT: BAKER BROS. ADVISORS LP, ALLIANCEBERNSTEIN L.P., Magnetar Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used